Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infants
Clinical trial NCT03765073 · COMPLETED
Trial details
- NCT number
- NCT03765073
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-14
- Primary completion
- 2024-03-04
- Enrollment
- 1208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.